Position in JNJ
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$2,008,140
-$2,105,540 QoQ
Shares Held
7,907
-53.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.38%
of 13F equity value
Holder Rank
#2,343
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GUARDIAN INVESTMENT MANAGEMENT holds $13,312,413 across 7 Drug Manufacturers - General names. JNJ ranks #3 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
16,205 | $5,868,154 | |
| 2 | ABBV |
AbbVie Inc.
|
12,425 | $3,126,627 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
7,907 | $2,008,140 | |
| 4 | BIIB |
Biogen Inc.
|
5,500 | $1,188,330 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,750 | $473,775 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
7,300 | $420,626 | |
| 7 | PFE |
Pfizer Inc
|
9,417 | $226,761 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,008,140 | 7,907 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $4,113,680 | 16,829 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $3,481,933 | 16,825 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $3,119,135 | 16,822 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,447,360 | 16,022 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $2,874,338 | 17,332 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $2,816,040 | 19,472 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $3,244,765 | 20,022 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $3,335,663 | 22,822 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $3,689,307 | 23,322 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $3,694,675 | 23,572 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $3,925,834 | 25,206 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $4,218,277 | 25,485 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $4,453,770 | 28,734 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $4,762,484 | 26,960 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $4,404,185 | 26,960 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $4,838,922 | 27,260 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $4,831,289 | 27,260 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $4,663,368 | 27,260 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $4,402,490 | 27,260 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $5,005,460 | 30,384 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $4,722,432 | 28,734 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $4,522,156 | 28,734 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $4,367,245 | 29,334 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $3,093,860 | 22,000 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $3,798,573 | 28,968 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||